Immuron (IMRN) Income from Continuing Operations (2016 - 2024)

Immuron (IMRN) recorded quarterly Income from Continuing Operations of 1.6602591656689772e+18 in Q4 2024, up 80082653894884.78% quarter-over-quarter from 2073182.0 in Q4 2023, and up 80082653894884.8% on a YoY basis from N/an in Q1 2024.

Immuron (IMRN) Income from Continuing Operations (2016 - 2024) Analysis & Trends

Immuron's Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 1.6602591656689772e+18 for Q4 2024.

  • In Q4 2024, Income from Continuing Operations rose 80082653894884.8% year-over-year to 1.6602591656689772e+18; the TTM figure through Dec 2024 stood at 1.6602591656656522e+18 (up 49735740978232.03% YoY), while the FY2025 annual figure was 3380634.04, up 25.69% from the prior year.
  • Income from Continuing Operations was 1.6602591656689772e+18 for Q4 2024 at Immuron, up from 2073182.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1.6602591656689772e+18 in Q4 2024 to a low of 2073182.0 in Q4 2023.
  • Historically, Income from Continuing Operations has averaged 2.7670986094426358e+17 across 5 years, with a median of 35323.95 in 2020.
  • The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations tumbled 15849.51% in 2023, then jumped 80082653894884.8% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 57387.72 in 2020, then soared by 76.89% to 13260.17 in 2021, then climbed by 1.97% to 12998.41 in 2022, then sank by 15849.51% to 2073182.0 in 2023, then surged by 80082653894884.78% to 1.6602591656689772e+18 in 2024.
  • The last three Income from Continuing Operations figures came in at 1.6602591656689772e+18 (Q4 2024), 2073182.0 (Q4 2023), and 1238720.54 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Immuron 921.61 Mn 921.58 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 1,660,259,165.67 Bn
Dec 31, 2023 -2.07 Mn
Jun 30, 2023 -1.24 Mn
Dec 31, 2022 -12,998.41
Dec 31, 2021 -13,260.17
Dec 31, 2020 -57,387.72
Dec 31, 2019 -15,212.27
Dec 31, 2018 -1.58 Mn
Dec 31, 2017 3.84 Mn
Dec 31, 2016 2.56 Mn
Jun 30, 2016 -3.28 Mn